Success Metrics

Clinical Success Rate
53.8%

Based on 14 completed trials

Completion Rate
54%(14/26)
Active Trials
13(20%)
Results Posted
64%(9 trials)
Terminated
12(18%)

Phase Distribution

Ph phase_1
3
5%
Ph phase_2
6
9%
Ph phase_3
3
5%
Ph not_applicable
49
75%

Phase Distribution

3

Early Stage

6

Mid Stage

3

Late Stage

Phase Distribution61 total trials
Phase 1Safety & dosage
3(4.9%)
Phase 2Efficacy & side effects
6(9.8%)
Phase 3Large-scale testing
3(4.9%)
N/ANon-phased studies
49(80.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

46.7%

14 of 30 finished

Non-Completion Rate

53.3%

16 ended early

Currently Active

13

trials recruiting

Total Trials

65

all time

Status Distribution
Active(16)
Completed(14)
Terminated(16)
Other(19)

Detailed Status

unknown19
Completed14
Terminated12
Recruiting11
Withdrawn4
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
65
Active
13
Success Rate
53.8%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (4.9%)
Phase 26 (9.8%)
Phase 33 (4.9%)
N/A49 (80.3%)

Trials by Status

terminated1218%
withdrawn46%
active_not_recruiting23%
unknown1929%
recruiting1117%
not_yet_recruiting35%
completed1422%

Recent Activity

Clinical Trials (65)

Showing 20 of 65 trialsScroll for more
NCT04430725

Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study

Active Not Recruiting
NCT04107766

NOLA (NeuWave Observational Liver Ablation) Registry

Terminated
NCT07528274Phase 2

Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure

Recruiting
NCT06426992Not Applicable

Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies

Recruiting
NCT06086002Not Applicable

Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma

Completed
NCT07291973Not Applicable

Clinical Investigation Evaluating the Performance, Safety and Clinical Benefit of the Endowave FlexAblate™ Microwave Ablation System in Patients Undergoing Lung Ablation Procedures.

Recruiting
NCT05673148Phase 3

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Recruiting
NCT07404670Not Applicable

Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety

Not Yet Recruiting
NCT04889989Not Applicable

Microwave Ablation in Chinese Patients With Lung Tumors

Terminated
NCT06128525Not Applicable

Prostate Resection After Microwave Ablation (PRAMA)

Completed
NCT04197960Not Applicable

Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma

Completed
NCT05953961Not Applicable

90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia

Recruiting
NCT06969014Not Applicable

Transbronchial MWA for Pulmonary Tumors

Recruiting
NCT04520906Not Applicable

To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer

Terminated
NCT03783871Not Applicable

NeuWave Microwave Ablation HCC China Study

Completed
NCT06802510Not Applicable

The Safety and Efficacy of Combined Microwave Ablation During Limb-sparing Surgery in High-risk Soft Tissue Sarcoma Patients

Completed
NCT06537505Phase 2

A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors

Not Yet Recruiting
NCT04220944Phase 1

Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.

Active Not Recruiting
NCT03586050Not Applicable

Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea

Completed
NCT03769129Not Applicable

Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC

Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
65